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Abstract

Author Manuscript

Post-traumatic stress disorder (PTSD) is a learning-based anxiety disorder with significant public
health challenges due to difficulties in treating the complex, multiple symptomology. We have
developed an animal model of PTSD, based on Pavlovian eyeblink conditioning in rabbits, that
addresses two key features: conditioned responses (CRs) to cues associated with an aversive event
and a form of conditioned hyperarousal referred to as conditioning-specific reflex modification
(CRM). We have found previously that unpaired extinction is ideal for reducing both CRs and
CRM simultaneously and shows sensitivity to systemic serotonergic and glutamatergic
manipulations. The following study aimed to extend our work to examine the role of the
noradrenergic system, dysregulation of which is strongly implicated as part of the neurobiology of
PTSD and which may also play a role in the balance shift from fear reconsolidation to extinction
during treatment. The goal of the following two studies was to examine whether the β-adrenergic
receptor antagonist propranolol combined with either a full or brief course of unpaired extinction
treatment could enhance extinction of CRs and/or CRM. Results showed a within-session
facilitation of propranolol on extinction of CRs, particularly during the first extinction session, and
a short-term enhancement of extinction of CRM when extinction treatment was brief. However,
neither benefit translated to long-term extinction retention for the majority of subjects. Findings
suggest that propranolol may provide the most therapeutic benefit in situations of high arousal
early in treatment, which may be more important for future patient compliance rather than longterm treatment outcomes.
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1. Introduction

Author Manuscript

Post-traumatic stress disorder (PTSD) is a multifaceted anxiety disorder that develops in
response to trauma exposure in approximately 7% of individuals in the United States
(Kessler et al., 2005), with estimates often higher in those exposed to military or combat
trauma (Donoho et al., 2017; Ramchand et al., 2010; but see also Wisco et al., 2016.
Treatment of PTSD remains a significant public health challenge due to difficulty in finding
treatments that can address the complex nature of PTSD symptomology, which includes
persistent re-experiencing of the event, avoidance of stimuli associated with trauma, and
generalized hyperarousal such as increased startle reflexes and hypervigilance (American
Psychiatric Association, 2013). Not surprisingly, research into the neurobiology of PTSD
has suggested the involvement of multiple neural/neurochemical systems that may each play
a role in one or more aspects of PTSD symptomology (Kelmendi et al., 2016; Pitman et al.,
2012). In addition, there is a learning, or more specifically, a dysfunctional fear conditioning
component underlying PTSD (Lissek and van Meurs, 2014; VanElzakker et al., 2014) that
cannot easily be resolved by pharmacological treatment alone. The use of cognitive
behavioral therapy aimed at extinguishing abnormally conditioned fear is another factor to
consider in the development of PTSD treatments, further increasing the pool of
pharmacological targets to include those that may be used in conjunction with therapy to
improve efficacy, by enhancing fear extinction for example (Fitzgerald et al., 2014;
Singewald et al., 2015). Because of the complexity of PTSD and the fact that it is often comorbid with other disorders such as depression, animal models are crucial to further our
understanding of why certain treatments work and how they may be combined to provide
better treatment outcomes in the clinical population.

Author Manuscript
Author Manuscript

We have developed an animal model of PTSD that addresses two key features: conditioned
responses (CRs) to trauma-associated cues and hyperarousal (Burhans et al., 2008; Schreurs
and Burhans, 2015). This model is based on conditioning of the rabbit’s nictitating
membrane response (NMR), also known as eyeblink conditioning. One of the unique aspects
of the eyeblink conditioning paradigm is that it has historically been used in both humans
and animals as a means of assessing associative learning (Solomon, 2002), allowing strong
translatability from the bench to the clinic and vice versa. While human studies have used it
to document learning phenotypes for disorders like schizophrenia (Kent et al., 2015;
Marenco et al., 2003) and anxiety disorders including PTSD (Burriss et al., 2007; Handy et
al., 2018), parallel work in animals has delineated the behavioral laws of acquisition and
extinction and the critical neural circuitry (Christian and Thompson, 2003; Freeman and
Steinmetz, 2011), giving a neurobiological perspective to those phenotypes. In a typical
experiment in our laboratory, rabbits are evaluated for reflexive eyeblink responding to
varying intensities (from 0.1 to 2.0 mA) of a periorbital shock unconditioned stimulus (US)
prior to and following eyeblink conditioning during which they learn to associate an auditory
tone conditioned stimulus (CS) with a 2.0-mA US. We have established that this paradigm
results in a form of hyperarousal called conditioning-specific reflex modification (CRM),
manifesting as increased and exaggerated responding to shock intensities, particularly lower
intensity shocks that elicited little or no responding prior to conditioning. CRM is
“conditioning-specific” in that it does not develop in the same way in rabbits that receive
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explicitly unpaired presentations of the CS and US. We have validated this model by
demonstrating it shares many commonalities with PTSD development; for example, CRM is
stronger when more aversive (i.e. more traumatic) stimuli are used as the US during
conditioning (Buck et al., 2001; Seager et al., 2003) and, like PTSD in the clinic, may
worsen after an incubation period (Schreurs et al., 2011a). Importantly, strong CRM only
develops in a limited number of subjects (Smith-Bell et al., 2012), just as not all those
exposed to trauma develop PTSD. We have also found that the amygdala, dysfunction of
which is strongly implicated in PTSD (Hughes and Shin, 2011), can modulate acquisition of
CRs to the tone CS and expression of CRM (Burhans and Schreurs, 2008). CRM-like
changes have also been documented by others in rabbits (Gruart and Yeo, 1995; Wikgren et
al., 2002) and rats (Servatius et al., 2001).

Author Manuscript
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In searching for behavioral treatments that can reduce PTSD-like symptoms in our model,
we have established an extinction treatment that can reduce both CRs and CRM
simultaneously (Burhans et al., 2015; Schreurs et al., 2011b). While CRs to the tone CS can
be extinguished by CS-alone presentations and CRM by US-alone presentations (but not
vice versa), extinction sessions including unpaired presentations of the CS and US can
extinguish both. Importantly, this can be achieved even when the US is reduced six-fold
from the training intensity (Schreurs et al., 2011b). In translating this to the clinic, our
findings suggest that adding random presentations of innately but mildly stressful stimuli
like skin stimulation to traditional therapies such as exposure therapy may help address the
hyperarousal symptoms of PTSD (Haesen and Vervliet, 2015). We have also been able to
use the CRM model to investigate pharmacological treatments, both alone and in
conjugation with behavioral extinction treatment. Previous work has delineated that different
aspects of our model are sensitive to serotonergic and glutamatergic manipulations (Burhans
et al., 2013, 2017), reinforcing the notion that a multi-factor approach to treatment is needed
to address multiple PTSD symptoms.

Author Manuscript

The following study aimed to further extend our work in the CRM model to examine the
role of the noradrenergic system. Dysregulation of norepinephrine (NE), normally released
during stressful or fearful situations as part of the fight or flight response, has been strongly
implicated as part of the neurobiology of PTSD (Hendrickson and Raskind, 2016;
Southwick et al., 1999; Strawn and Geracioti, 2008). In support of this, for example, it has
been found that NE is elevated in PTSD patients both at baseline levels and in response to
trauma-associated stimuli (Blanchard et al., 1991; Geracioti et al., 2001; Liberzon et al.,
1999). The crucial role NE plays in emotional arousal and modulation of emotional memory
formation is believed to occur specifically through actions at β-adrenergic receptors
(McIntyre et al., 2012), making these receptors a prime target for pharmaceutical
intervention. Propranolol is a β-adrenergic receptor antagonist historically prescribed as a
treatment for hypertension that has gained renewed interest as a treatment for PTSD,
although with some mixed results (Giustino et al., 2016; Southwick et al., 1999). Systemic
propranolol has also been previously examined in eyeblink conditioning paradigms and was
found to impair acquisition in both rabbits (Gould, 1998) and rats (Cartford et al., 2002),
although effects on extinction are less clear with some evidence for enhancement (Gould,
1998). However, there is a vast literature supporting a role for propranolol in enhancing fear
extinction and blocking fear memory reconsolidation in animal models as well as healthy
Neuropharmacology. Author manuscript; available in PMC 2019 June 01.
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humans (Giustino et al., 2016). In the following series of two experiments, we tested the
hypothesis that propranolol could enhance extinction of CRs and CRM in our rabbit model
of PTSD. In the first experiment, we assessed the effects of propranolol combined with a
full, six-session course of unpaired extinction treatment with weak shock. In Experiment 2,
we assessed the effects of propranolol combined with a brief course of unpaired extinction,
which we have previously shown to be less successful at extinguishing CRs and CRM, with
evidence it may even worsen CRM (Schreurs et al., 2011b).

2. Materials and Methods
2.1 Subjects

Author Manuscript

The subjects were 43 male, New Zealand White rabbits (Oryctolagus cuniculus), 2–3
months of age weighing approximately 1.8–2.3 kg upon delivery from the supplier (Harlan,
Indianapolis, IN). Prior to behavioral training, one rabbit was removed due to a failure to
adapt to restraint. Rabbits were housed in individual cages on a 12 hour light-dark cycle and
given ad libitum access to food and water. They were maintained in accordance with the
guide for the care and use of laboratory animals issued by the National Institutes of Health,
and the research was approved by the West Virginia University Animal Care and Use
Committee.
2.2 Apparatus

Author Manuscript

The apparatus and recording procedures for NMR conditioning have been detailed elsewhere
by Schreurs and Alkon (1990) who modeled their apparatus based on those described by
Gormezano (Coleman and Gormezano, 1971; Gormezano, 1966). Briefly, rabbits were
restrained in a Plexiglas box placed inside a sound-attenuating, ventilated chamber
(Coulborn Instruments, Allentown, PA; Model E10-20). Inside the chamber, a stimulus
panel containing a speaker and houselight (10-W, 120 V) was mounted at a 45° angle 15 cm
anterior and dorsal to the rabbit’s head. An exhaust fan created a constant ambient noise
level of 75 dB inside the chamber. Periorbital electrical stimulation was delivered by a
programmable two-pole stimulator (Colbourn Instruments, Model E13-35) via stainless steel
Autoclip wound clips (Stoelting, Wood Dale, IL) that were positioned 10 mm ventral and 10
mm posterior to the dorsal canthus of the right eye. Stimulus delivery, data collection, and
analysis were all accomplished using the LabVIEW software system (National Instruments,
Austin, TX).

Author Manuscript

The NMRs were transduced by a potentiometer (Novotechnik US Inc., Southborough, MA;
Model P2201) connected at one end, via a freely moving ball and socket joint, to an Lshaped lever containing a hook that attached to a 6-0 nylon loop that was sutured into but not
through the nictitating membrane (NM). At the other end, the potentiometer was connected
to a 12-bit analog-to-digital converter (5-ms sampling rate, 0.05-mm resolution), and
individual A/D outputs were stored on a trial-by-trial basis for subsequent analysis.
2.3 Procedure
One week after arrival, rabbits were first acclimated to restraint by being placed in
restrainers for 30 minutes while under close supervision. Rabbits then received one training
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session per day in the following order: adaption, US pretest, six sessions classical delay
conditioning, US posttest (Post1), six sessions unpaired extinction with weak shock
combined with either propranolol or saline, a second US posttest (Post2), and a CS-alone
retention test (CS Test). Comparisons of Post1 with Pretest served as the initial evaluation of
CRM while Post2 measured the amount of remaining CRM following extinction treatment
with or without propranolol. The NMR responses to the tone CS during extinction served as
a measurement of the immediate, within-session effects of propranolol on the extinction of
CRs while the responses measured during the CS Test served as a post-treatment assessment
of the remaining level of CRs.

Author Manuscript

For adaptation, subjects were prepared for delivery of the periorbital shock US and NMR
recording and then adapted to the training chambers for an amount of time equivalent to
subsequent training sessions (80 min). For pretest and posttests, subjects received 80 trials of
US presentations with an average inter-trial interval (ITI) of 60 s (range 50–70 s). Each US
presentation was one of 20 combinations of periorbital shock intensity (0.1, 0.3, 0.5, 1.0, or
2.0 mA) and duration (10, 25, 50, or 100 ms), and these 20 unique USs were presented in
four separately randomized blocks with the restriction that the same intensity or duration
could not occur more than three times in succession. For delay conditioning, each session
consisted of 80 trials of paired presentations of a 400 ms, 1 kHz, 82 dB CS that coterminated
with a 100 ms, 2.0 mA US (300 ms interstimulus interval). The CS-US presentations were
presented with an average ITI of 60 s. Unpaired extinction with weak shock consisted of 80
presentations of the tone CS and 80 presentations of a 0.3 mA US (100 ms) that were
explicitly unpaired and presented in a pseudorandom order. To maintain the session length at
approximately 80 minutes, the average ITI for unpaired sessions was reduced to 30 s. The
CS Test consisted of 80 presentations of the tone CS with an average ITI of 60 s.

Author Manuscript

2.4 Propranolol Injections
For each day of propranolol injections, a fresh stock solution of 24 mg/ml of propranolol
hydrochloride (Spectrum Chemicals; VWR, Bridgeport, NJ) was prepared by dissolving in
0.9% sterile saline. Rabbits were divided into four groups receiving intramuscular injections
of 0.9% saline or 3 mg/kg, 6 mg/kg, or 12 mg/kg propranolol 30 minutes prior to the start of
each of six sessions of unpaired extinction. To equate injection volume, serial dilutions of 12
mg/ml and 6 mg/ml were prepared from the stock propranolol solution for the 6 mg/kg and 3
mg/kg groups, respectively.
2.5 Statistical Analysis

Author Manuscript

Conditioned responses (CRs) of the NMR were defined as any extension of the NM
exceeding 0.5 mm that was initiated following CS onset but prior to US onset. For US pre
and posttests, an unconditioned response (UR) was defined as any extension of the NM
exceeding 0.5 mm that was initiated within 300 ms following US onset. The definition of the
UR was based on prior observations that responses to the US following CS-US pairings had
onset latencies within the same range as CRs (Schreurs et al., 2000). Amplitude of the
response was calculated as the maximum extension of the NM in millimeters. Onset latency
of the response was the latency in ms from stimulus onset to when the NM rose 0.1 mm
above baseline while peak latency was the latency in ms from stimulus onset until maximum
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NM extension occurred. Area of the response was calculated as the total area of the response
curve (arbitrary units, au) from stimulus onset until the end of trial (trial length = 2000 ms).

Author Manuscript

For URs during US testing, two additional measures were calculated in order to overcome
the statistical limitations of empty data cells produced by subthreshold responses to
periorbital shock, particularly at the lower intensities and durations. These measures,
magnitude of the response amplitude (mAmp) and magnitude of the response area (mArea),
included the amplitudes and areas of all NMRs above baseline regardless of whether the 0.5
mm criterion was met (Garcia et al., 2003). A significant pre- to posttest increase in any of
the UR response measures as a function of classical conditioning is a defining feature of
CRM. To increase the sensitivity for detection of CRM and to follow the convention of
previous CRM studies, data were collapsed at the five US intensities across duration and
CRM analyses were focused on the first 20 trial US sequence where the strongest CRM is
observed (Schreurs et al., 2000). To examine the shape and timing of NMRs during US tests,
response topographies were generated at each US intensity by averaging across rabbits and
across US durations within each experimental group.
The experiment was conducted in three separate replications. Drug groups were assigned
following NMR conditioning and CRM testing in order to equate groups for learning and
CRM levels. Unless otherwise indicated, data were analyzed by repeated measures analysis
of variance (ANOVA, SPSS 21). For violations of sphericity, p-values reflect corrections
using procedures of Huynh-Feldt. Planned and follow-up comparisons were Bonferroni
corrected for the number of comparisons.

Author Manuscript

Additionally, rabbits were evaluated for individual variation in the strength of CRM.
Following the convention of previous publications (Smith-Bell et al., 2012; Smith-Bell and
Schreurs, 2017), mean percent change in UR frequency, mArea, and mAmp from Pretest to
Post1 at each US intensity was calculated for saline and propranolol groups combined.
Rabbits exhibiting a percent change greater than or equal to two standard deviations above
the mean percent change were categorized as having strong CRM.

3. Results
3.1 Delay Conditioning

Author Manuscript

Two rabbits were removed from all analyses due to a failure to reach a learning criterion of
80% CRs by the last day of conditioning, resulting in final n’s of 10 subjects per group. The
average percentage of CRs to the tone CS across six sessions of classical delay conditioning
is shown on the left side of Figure 1. Rabbits rapidly acquired a high level of conditioning
with averaged final percent CRs in excess of 98% (± 0.44 SEM), as confirmed by a
significant effect of Session [F(5,180)= 142.2, p < 0.001] with corrected planned
comparisons indicating CRs increased from the first to second session (p < 0.001) and
remained at a similar high level for the remaining days of training. There were no significant
differences between groups, demonstrating that all groups were equivalent in learning rate
and level prior to drug manipulations during extinction.
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The average percentage of CRs to the tone CS across six sessions of unpaired extinction
with weak shock is shown in the middle of Figure 1. Treatment with propranolol thirty
minutes prior to the start of the extinction session appeared to have a dose-dependent effect
on CRs, with the highest dose group (12 mg/kg) showing the lowest level of CRs, followed
by the middle (6 mg/kg) and then low (3 mg/kg) dose groups, with the low dose being most
similar to saline injected controls. Analysis of all six sessions of extinction indicated a trend
for a main effect of Drug Group [F(3,36) = 2.43, p = 0.071] and a trend for an interaction of
Session and Drug Group [F(15, 180) = 1.77, p = 0.086]. When analysis was restricted to
comparisons of the 12 mg/kg dose with saline controls, there was a significant effect of Drug
Group [F(1,18) = 7.57, p < 0.05] but no interaction with Session, demonstrating that CRs
were lower for the 12 mg/kg dose compared to saline throughout extinction.

Author Manuscript

Analyses of other CR parameters (latency, amplitude, area) at each extinction day did not
reveal any effects of Drug Group with the exception of a main effect on the fifth session of
extinction for CR amplitude [F(3,24) = 4.55, p < 0.05] and CR area [F(3, 24) = 3.36, p <
0.05], with corrected post hocs indicating that the 3 mg/kg group had larger CRs for both
measures compared to saline and the 12 mg/kg groups (all p’s < 0.05). There were no
significant drug effects on the UR for US-alone trials during extinction for UR frequency
(see boxed inset in Figure 1), nor for latency, area, or amplitude measures.

Author Manuscript
Author Manuscript

In order to look in more detail at whether propranolol was affecting within-session
extinction, the extinction sessions were graphed by 10-trial blocks of CS-alone trials, shown
in Figure 2. Importantly, at the beginning of the first extinction session, all groups appeared
to be performing at a similar level. As the first extinction session proceeded, the 12 mg/kg
group exhibited the greatest decrease in responding, suggesting that propranolol enhanced
within-session extinction rather than producing a performance or memory deficit. Analysis
of 10-trial blocks for the first versus last 10 trials of the extinction session across all six
sessions yielded no significant group effects. However, a focused analysis of the 12 mg/kg
group compared with the saline controls indicated a significant interaction of Session, Block,
and Drug Group [F(5,90) = 3.785, p < 0.05]. After Bonferroni corrections of planned
comparisons, there was only a trend for lower CRs in the 12 mg/kg dose during the last
block of the first extinction session (p =.06), suggesting that lower overall CR levels in the
propranolol group across extinction sessions was more likely the result of facilitation of
extinction, rather than a performance or memory deficit. By the end of extinction, however,
the saline and lower dose drug groups were catching up to the terminal levels of extinction
exhibited by the 12 mg/kg group. To measure extinction retention, comparisons of the last
block with the first block of the subsequent extinction session revealed the 12 mg/kg group,
but not saline controls, showed an increase in percent CRs from the first to the second
session, demonstrating poor extinction retention (p< 0.01).
During the CS Test that took place two days following the last session of extinction, the 12
mg/kg propranolol group was observed to be at a similar, but slightly higher, level of
responding than saline controls (right side of Figure 1). In confirmation, analysis of the CS
Test revealed that there were no group differences when analysis included either all groups
or just comparisons of saline controls with the 12 mg/kg group. In addition, no group effects
Neuropharmacology. Author manuscript; available in PMC 2019 June 01.
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emerged from examining the CS Test data divided into blocks. These results confirm that the
highest dose propranolol group lost its early advantage during extinction, with all groups
subsequently demonstrating similar levels of CRs at the CS Test.
3.3 Conditioning-Specific Reflex Modification

Author Manuscript

Prior to propranolol injections during extinction, all groups demonstrated significant CRM at
Post1, as evidenced by Pretest to Post1 increases in several UR measures, particularly at the
intermediate intensities for which CRM tends to be strongest (Burhans et al., 2008).
Changes in the amplitude, area, and latency of the UR can be discerned by the UR
topographies in Figure 3. Increases in area and amplitude of the UR were confirmed by
significant Test (Pretest vs Post1) by Intensity interactions for mAmp [F(4,144) = 8.20, p <
0.001] and mArea [F(4,144) = 5.94, p < 0.001] with corrected planned comparisons
indicating significant increases for both measures at the 0.5 mA intensity (p’s< 0.05).
Amplitude and area increases were also found at 0.3 mA but were not statistically significant
following Bonferroni correction. Due to the limitations of empty data cells (see Methods),
analyses of latency measures were conducted at each intensity separately. For onset latency,
the only Pre to Post1 change occurred at the 2.0 mA intensity [F(1,36) = 6.60, p< 0.05]:
however, it was the result of a decrease in latency. For peak latency, there were significant
Pre to Post1 increases at the 0.3 [F(1,27) = 21.76, p< 0.001], 0.5 [F(1,33) = 19.65, p
<0.001], and 1.0 mA [F(1,36) = 7.63, p < 0.01] intensities and a decrease at 2.0 mA [F(1,36)
= 5.61, p< 0.05]. There were no significant Pre to Post1 changes in the UR frequency. There
were no group differences in CRM for any of the UR measures, indicating that the groups
were equivalent prior to propranolol and extinction treatment.

Author Manuscript

Evaluation of individual variation in the strength of CRM revealed that only 22.5% of
rabbits exhibited strong CRM for at least one of the intermediate intensities, 0.3, 0.5, or 1.0
mA for %UR, mAmp, or mArea. This finding is similar to percentages reported in previous
publications utilizing much larger databases of rabbit data (Smith-Bell et al., 2012; SmithBell and Schreurs, 2017). The incidence of strong CRM was not evenly distributed among
groups as saline, 3 mg/kg, 6 mg/kg, and 12 mg/kg propranolol groups had 3, 0, 4, and 2
rabbits with strong CRM, respectively.
3.4 Effects of Propranolol on Extinction of Conditioning-Specific Reflex Modification

Author Manuscript

Effects of propranolol combined with six sessions of unpaired extinction were evaluated at
Post2, one day following the last extinction session (see Figure 3). All groups appeared to
show significant decreases in CRM regardless of drug treatment, with area, amplitude, and
peak latency changes returning to Pretest levels. Analyses of mAmp and mArea focused on
the intensities for which the greatest initial CRM was found, 0.3 and 0.5 mA. There was a
significant effect of Test (Pre, Post1, Post2) for both mAmp [(F(2,72) = 6.36, p < 0.01] and
mArea [F(2,72) = 9.72, p < 0.001] with corrected post hoc tests indicating that Post2 was
decreased relative to Post1 for both measures (p’s < 0.001) and not statistically different
from Pretest. There were no significant interactions with Intensity (0.3, 0.5 mA) or
significant effects involving Drug Group. For peak latency, analyses at each of the three
intensities showing significant initial CRM (0.3, 0.5, 1.0 mA) indicated a significant effect
of Test at only the 0.5 mA intensity [F(2,64) = 16.11, p < 0.001], with corrected post hoc
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tests indicating that Post2 was reduced compared to Post1 (p < 0.001) and not significantly
different than Pretest. Again, there were no effects involving Drug Group. There were not
enough rabbits exhibiting strong CRM in each group to conduct additional analyses to
examine whether strength of CRM would affect response to propranolol treatment.

4. Experiment 2

Author Manuscript

Results from the first experiment collaborated previous studies demonstrating that six days
of unpaired extinction with weak shock is effective at reducing both CRs and CRM (Burhans
et al., 2015; Schreurs et al., 2011b). This raised the possibility that floor effects may have
accounted for the failure to see effects of propranolol on extinction of CRM or long-term
effects on the extinction of CRs. A second experiment was conducted to examine if
propranolol would be more beneficial when a brief course of treatment was utilized. A
single session of unpaired extinction with weak shock has previously been shown to be less
effective at reducing CRs than three or six days of treatment, with evidence that it may
increase the size of CRM (Schreurs et al., 2011b). In Experiment 2, we investigated the
effects of propranolol combined with a single day of unpaired extinction with weak shock
using the propranolol dose that enhanced within-session extinction of CRs in the first
experiment (12 mg/kg).

5. Materials and Methods
5.1 Subjects

Author Manuscript

The subjects were 35 male, New Zealand White rabbits (Oryctolagus cuniculus), 2-3 months
of age weighing approximately 1.8–2.3 kg upon delivery from the supplier (Charles River,
Saint-Constant, Canada). Of some importance is the change in vendor for the rabbits used in
Experiment 2 due to closure of the original vendor, which was the source for the majority of
past publications on the CRM model. The old and new vendors were located in different
countries (USA vs Canada), used separate stock breeds of New Zealand rabbits, and also had
different handling and enrichment protocols. We had concerns when we observed rabbits
from the new vendor appeared to have increased baseline sensitivity to the periorbital shock
US at Pretest and a lower incidence of CRM. For this reason, we used a larger sample of
animals per group for Experiment 2 than for the first experiment.

Author Manuscript

Prior to behavioral training, two rabbits were removed due to a failure to adapt to restraint.
Rabbits were housed in individual cages on a 12 hour light-dark cycle and given ad libitum
access to food and water. They were maintained in accordance with the guide for the care
and use of laboratory animals issued by the National Institutes of Health, and the research
was approved by the West Virginia University Animal Care and Use Committee.
5.2 Procedure
The apparatus and stimulus parameters of the training sessions in Experiment 2 were
identical to those in Experiment 1. Following restraint acclimation, rabbits received one
training session per day in the following order: adaptation, US pretest, six sessions classical
delay conditioning, Post1, one session of unpaired extinction with weak shock combined
with12 mg/kg propranolol or saline, and Post2. One week later, rabbits received a third US
Neuropharmacology. Author manuscript; available in PMC 2019 June 01.
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posttest (Post3) and a CS Test. NMR responses to the CS during extinction and to the US
during Post2 evaluated the more immediate effects of a single day of extinction treatment
with or without propranolol on CRs and CRM, respectively. Post3 and the CS Test examined
the level of remaining CRM and CRs, respectively, one week after treatment. Prior to the
single unpaired extinction session, a fresh stock solution of 24 mg/ml of propranolol
hydrochloride (Spectrum Chemicals; VWR, Bridgeport, NJ) was prepared by dissolving in
0.9% sterile saline. Rabbits were divided into two groups receiving either saline or 12 mg/kg
propranolol 30 minutes prior to the start of the session. Procedures for statistical analyses
were identical to those in the first experiment.

6. Results
6.1 Delay Conditioning

Author Manuscript
Author Manuscript

One rabbit was removed from all analyses due to excessive spontaneous blinking. Two
additional rabbits were removed from all analyses because they exhibited extremely large
responses during Pretest and were mathematically confirmed to be outliers based on the area
and amplitude of their URs. Final n’s per group were 14 and 16 for the saline and
propranolol groups, respectively. The average percentage of CRs to the tone CS across six
sessions of delay conditioning is shown on the left side of Figure 4. Rabbits rapidly acquired
a high level of conditioning with averaged final percent CRs in excess of 96% (± 1.3 SEM),
as confirmed by a significant effect of Session [F(5,140) = 148.55, p < 0.001] with corrected
planned comparisons indicating CRs increased from the first to second session (p < 0.001),
further increased from the second to third session (p < 0.05), and then stayed at a similar
high level during subsequent sessions. There were no significant differences between
groups, demonstrating that both saline and propranolol groups were equivalent in learning
rate and level prior to drug manipulations during extinction.
6.2 Effects of Propranolol on Extinction of Conditioned Responses

Author Manuscript

The average percentage of CRs to the tone CS across a single day of unpaired extinction
with weak shock is shown in the middle of Figure 4, averaged for both the entire session and
in blocks of 10 CS-alone trials. Similar to findings in Experiment 1, treatment with 12
mg/kg propranolol thirty minutes prior to the start of the extinction session produced a
within-session facilitation of extinction. These observations were confirmed by a significant
main effect of Drug Group for the analysis of the entire session [F(1,28) = 6.16, p < 0.05],
and a significant Drug Group and Block interaction when the first and last blocks of
extinction were compared [F(1,28) = 4.54, p < 0.05]. Corrected post hoc tests indicated that
saline and propranolol groups did not differ at the start of the extinction session, but by the
end of the session, propranolol rabbits had significantly lower CR levels than saline controls
(p < 0.05). Analyses of other CR parameters (latency, amplitude, area) did not reveal any
effects of Drug Group with the exception of CR area, which was found to be decreased in
the propranolol group [F(1,28) = 7.15, p < 0.05]. Unlike analyses of percent CRs, there was
no effect of Block for CR area, indicating this was an overall decrease rather than a withinsession extinction effect. Analyses of URs on US-alone trials during the extinction session
did not reveal any differences between saline and propranolol groups for UR frequency (see
Figure 4 boxed insert) or other response parameters.

Neuropharmacology. Author manuscript; available in PMC 2019 June 01.

Burhans et al.

Page 11

Author Manuscript

The averaged percent CRs for the CS Test, which took place eight days following the
extinction session (one day after Post3), can be seen on the right side of Figure 4. Analysis
of the entire session as well as the session divided into blocks did not reveal any effects of
Drug Group. An analysis was also done to compare the last 10 CS-alone trials of the
extinction session with the first ten trials of the CS Test in order to specifically examine
extinction retention. There was a significant interaction of Drug Group and Session [F(1,28)
= 5.94, p< 0.05] with corrected planned comparisons indicating that the group difference at
the end of extinction (p < 0.05) was no longer present during the beginning of the CS Test.
Increases in responding from the level exhibited at the end of extinction occurred in both
saline (p< 0.05) and propranolol groups (p< 0.001), demonstrating some recovery of the CR
which was greater in the propranolol group.
6.3 Conditioning-Specific Reflex Modification

Author Manuscript

Changes in the amplitude, area, and latency of the UR can be discerned by the UR
topographies in Figure 5. Analysis of the initial level of CRM prior to propranolol treatment
revealed significant Test (Pretest, Post1) by Intensity interactions for mAmp [F(4,112) =
3.91, p < 0.01] and mArea [F(4,112) = 6.86, p< 0.001]. Although there were Pretest to Post1
increases at the intermediate intensities (0.3 and 0.5 mA) for both measures, the
comparisons were not significant. For latencies measures, there were significant Pretest to
Post1 increases in onset latency at the 0.3 [F(1,21) = 9.9, p < 0.01], 0.5 [(F(1,28) = 6.16, p <
0.05], and 1.0 mA [F(1,27) = 20.25, p < 0.001] intensities and in peak latency also at the 0.3
[F(1,21) = 12.07, p < 0.01], 0.5 [F(1,28) = 15.36, p < 0.01], and 1.0 mA [F(1,27) = 17.64, p
< 0.001] intensities. Significant CRM was not found in analyses of UR frequency.

Author Manuscript

Compared to the first experiment, a smaller percentage of rabbits (16.6% versus 22.5%)
exhibited strong CRM at the intermediate intensities (0.3, 0.5, or 1.0 mA) for %UR, mAmp,
or mArea. Of those with strong CRM, two rabbits were in the saline control group and three
in the 12 mg/kg propranolol group.
6.4 Effects of Propranolol on Extinction of Conditioning-Specific Reflex Modification

Author Manuscript

Effects of propranolol combined with a single day of unpaired extinction on CRM can be
seen in the UR topographies in Figure 5 (Post2) and in bar graphs for the intermediate
intensities in Figure 6. Following extinction, the size of CRM present at the intermediate
intensities at Post1 appeared to remain relatively intact in saline controls at Post2 but
diminished in the propranolol group, possibly to below Pretest levels. Analyses of mAmp
and mArea focused on the two intensities where CRM occurred prior to extinction treatment,
0.3 and 0.5 mA. For mAmp, there was a trend for an interaction of Test (Pretest, Post1,
Post2) and Drug Group [F(2,56) = 2.97, p = 0.060] and a trend for an interaction of Test,
Drug Group, and Intensity [F(2,56) = 0.16, p = 0.059]. Corrected planned comparisons for
the Test by Drug Group effect revealed that the propranolol group at Post2 had a reduced
amplitude relative to Pretest (p < 0.05) and Post1 (trend, p = 0.067) whereas no differences
were found at Post2 in the saline group. Corrected planned comparisons of the interaction
involving Intensity indicated that for the propranolol group, responding at Post2 was
decreased relative to Pretest at the 0.3 mA intensity, but was only a trend following
Bonferroni correction (p = 0.096). For mArea, there was a significant Test, Drug Group, and
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Intensity interaction [F(2,56) = 0.96, p < 0.05] with planned comparisons indicating that
only the propranolol group demonstrated decreases in area at Post2 relative to both Pretest
and Post1 at the 0.3 mA intensity and relative to Post1 at the 0.5 mA intensity, but only the
latter comparison survived Bonferroni correction (strong trend, p = 0.054).

Author Manuscript

In contrast to the effect of propranolol on the size of CRM following extinction, the peak
latency shift aspect of CRM appeared to decrease in both groups at Post2. Confirming this
observation, there was a main effect of Test (Pretest, Post1, Post2) and no interaction with
Drug Group at the intensities with significant CRM prior to treatment: 0.3 mA [F(2,32) =
8.54, p < 0.01], 0.5 mA [F(2,52) = 5.25, p < 0.01], and 1.0 mA [F(2,54) = 11.67, p< 0.001].
Corrected planned comparisons indicated that there were no differences in peak latency
between Post2 and Pretest for all three intensities, and there was a decrease in latency from
Post1to Post2 at 0.3 mA and 1.0 mA (p’s < 0.01). For onset latency, there were also no
significant effects of Drug Group. There was a main effect of Test at 1.0 mA [F(2,54) =
11.05, p < 0.001] with corrected planned comparisons indicating that onset latency at Post2
remained greater than Pretest (p < 0.05). Therefore, although the peak latency shift aspect of
CRM was diminished after extinction, some onset latency changes remained intact.

Author Manuscript

At the assessment of CRM one week after Post2 (Post3), any benefit of combined
propranolol and extinction treatment on reducing the size of CRM appeared to be transient.
In confirmation, analysis of Post3 compared to Pretest and Post1 at intensities for which
CRM was significant prior to treatment did not indicate any significant effects involving
Drug Group for amplitude or area measures. There were also no drug effects for latency
measures. Instead, at Post3, amplitude and area measures were not significantly different
from Pretest or Post1, suggesting an intermediate level of CRM remained in both groups.
For latency measures, the increased latency indicative of CRM at Post1 was diminished at
Post3. For onset latency, there was a significant effect of Test at 0.3 [F(2,38) = 7.32, p <
0.01], 0.5 [F(2,54) = 5.88, p < 0.01] and 1.0 mA[F(2,52) = 13.30, p< 0.001], with corrected
follow up comparisons indicating that CRM was decreased from Post1 levels (all p’s < 0.01)
and not significantly different from Pretest. The same pattern of decreased latency at Post3
compared to Post1 (all p’s < 0.01) and no difference from Pretest occurred for peak latency
also at 0.3 [F(2,38) = 9.876, p < 0.01] and 1.0 mA [F(2.52) = 12.66, p < 0.001]. For peak
latency at 0.5 mA, corrected follow up comparisons on a main effect of Test [F(2,54) = 3.77,
p < 0.05] indicated that Post3 was not statistically different from Pretest or Post1. Therefore,
the initial CRM observed for latency measures showed no signs of recovery for either group
one week following extinction treatment.

Author Manuscript

Although there were not enough rabbits exhibiting strong CRM in each group to statistically
examine whether the strength of CRM would affect response to propranolol treatment,
individual topographies were examined to see if any patterns emerged between CRM levels
and treatment response. Figure 7 shows several examples of individual topographies of
propranolol rabbits identified as having strong (top row) or moderate (bottom row) levels of
CRM at intermediate US intensities. The top row shows two rabbits with strong CRM, with
the left subject demonstrating strong CRM at the 0.5 mA and 1.0 mA intensities for both the
area and amplitude of the UR and the right subject showing strong CRM for the UR
amplitude at 0.3 mA. For these large changes in responding, propranolol combined with a
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single day of unpaired extinction treatment appeared to reduce CRM (Post2) with effects
lasting one week (Post3). But of importance to note is that within those same subjects,
responding at intensities where there was more moderate CRM did not show long-lasting
reductions in CRM (see Post3 responses to 0.3 mA in the top left and 0.5 mA in the top right
topographies). The bottom row shows two propranolol rabbits with more typical, moderate
levels of CRM, with the subject on the left showing long-lasting reductions in CRM
following combined treatment, contrasted with the subject on the right showing treatment
resistance. Clearly, these qualitative observations demonstrate a great deal of inter- and intrasubject variability in response to treatment, with some suggestion that propranolol may
produce longer lasting benefits for the most extreme responses. However, further evaluation
requires a much larger sample of subjects with strong CRM, which is beyond the scope of
the current experiment.

Author Manuscript

7. Discussion

Author Manuscript

Results from Experiment 1 demonstrated that propranolol administered prior to sessions of
unpaired extinction with weak shock initially facilitated extinction of CRs to the tone CS in
a dose-dependent manner. However, by the end of extinction training, saline controls were
able to catch up to the extinction levels exhibited by propranolol subjects. During later
testing without the drug, there was no evidence that propranolol enhanced extinction
retention. There was also no evidence that propranolol had any effect on extinction of CRM,
as both control and propranolol groups showed similar reductions in CRM. Because of the
possibility of floor effects due to the success of six sessions of unpaired extinction treatment
in reducing both CRs and CRM in control subjects, Experiment 2 examined the effects of
propranolol using only a single day of unpaired extinction, a treatment previously shown to
be inferior to the full course of treatment that may even worsen CRM (Schreurs et al.,
2011b). Similar to results from Experiment 1, propranolol facilitated within-session
extinction of CRs to the tone CS but did not enhance extinction memory as propranolol
subjects were back up to control levels during later retention testing. Propranolol did
enhance extinction of the size of CRM with the short course of extinction, but again, this
effect was transient and did not enhance retention of CRM extinction when tested a week
later. However, examination of individual variations in the strength of CRM did suggest that
propranolol may have longer lasting effects on responses characterized as strong CRM.
Overall, these findings suggested a within-session benefit of propranolol on extinction of
CRs and a short-term benefit on extinction of CRM when extinction treatment is brief/
insufficient, but neither benefit translated to improved long-term treatment outcomes for the
majority of subjects.

Author Manuscript

Our findings on propranolol’s facilitation of extinction add to the inconsistencies in the
animal literature. To our knowledge, there is only one other study that examined the effects
of propranolol on extinction of eyeblink conditioning, also in rabbits and of note, also using
unpaired extinction (Gould, 1998). Although results on extinction were less clear due to
smaller subject size and confounding effects of subjects receiving propranolol throughout
both acquisition and extinction, there was some suggestion that propranolol decreased the
number of days to reach an extinction learning criterion. For rodent fear conditioning
models, there have been conflicting reports on the role of noradrenergic blockade on
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extinction (as reviewed in Giustino et al., 2016; Mueller and Cahill, 2010). In some cases,
propranolol has been shown to impair extinction learning and retention (Fitzgerald et al.,
2015; Mueller et al., 2008). In other cases, propranolol has been shown to reduce expression
of fear without necessarily enhancing extinction learning or extinction retention per se
(Rodriguez-Romaguera et al., 2009). Because our paradigm does not include a direct
measure of fear such as freezing, our results do not rule out of the possibility that
propranolol is reducing overall fear during extinction but do suggest that extinction learning
itself seems to be impacted by propranolol, at least in the short-term. The lack of long-term
effects of propranolol on retention of extinction of CRs and CRM may have several
explanations. One interpretation to consider is that undergoing extinction in a drug state may
constitute a change in context (i.e. internal state) that allows fear renewal to occur when later
testing for extinction retention occurs in a drug-free state (Radulovic et al., 2017), and the
other possibility is simply spontaneous recovery of responding, occurring perhaps to a
greater degree in the propranolol group (Bouton, 2002).

Author Manuscript
Author Manuscript

One of the ideas about the role NE may play in extinction learning is based on the delta rule
(Rescorla and Wagner, 1972), whereby the violation of expectancy that occurs during
extinction (i.e. the CS is no longer paired with the US) triggers retrieval of the original CSUS association during and for some time after extinction training (Ouyang and Thomas,
2005). It is believed that retrieval of that memory makes it labile (Alberini and Ledoux,
2013; Nader and Hardt, 2009), which can lead to either fear reconsolidation or consolidation
of a new extinction memory depending on the circumstances, and the retrieval process itself
seems to be sensitive to β-adrenergic manipulations (Ouyang and Thomas, 2005). There is a
substantial body of evidence that β-receptor blockers such as propranolol can impair fear
memory reconsolidation in animals, particularly in situations where there is a high arousal
level, thereby shifting the balance more towards fear extinction (as reviewed in Giustino et
al., 2016). For example, recent work in rats has shown that systemic propranolol prior to
extinction learning reduces within session freezing and importantly enhances extinction
retention if extinction takes place shortly after conditioning rather than 24 hours later
(Fitzgerald et al., 2015). Normally extinction deficits occur with immediate extinction,
presumably because emotional arousal levels remain high from the fear conditioning
session, but this can be overcome by NE blockade with propranolol. Although our paradigm
involves delayed rather than immediate extinction, the fact that we used unpaired extinction
where shock is still presented along with CS-alone presentations is likely to create a higher
state of arousal and resulting increases in circulating NE. Indeed, unsignaled shock has been
shown to increase NE levels in brain areas associated with emotional arousal such as the
amygdala (Galvez et al., 1996; Ronzoni et al., 2016), and intra-amygdalar injections of
propranolol prior to shock exposure can ameliorate fear behavior (Ronzoni et al., 2016).
Therefore, a higher arousal level induced by unpaired extinction may explain why we found
some facilitation of extinction with propranolol, possibly as a result of modulation of
amygdalar NE. This is feasible with systemic propranolol as it does cross the blood-brain
barrier (Neil-Dwyer et al., 1981; Pardridge et al., 1984). We have previously shown that
inactivation of the amygdala abolishes CRM expression (Burhans and Schreurs, 2008),
suggesting that actions of propranolol on amygdalar NE levels may also contribute to the
decreased CRM observed in Experiment 2 following brief extinction.
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Another possible site of action of NE in our paradigm is the cerebellum, with the
interpositus nucleus (IP) in the deep cerebellar nuclei (DCN) being a critical neural substrate
for eyeblink conditioning (Christian and Thompson, 2003; Freeman and Steinmetz, 2011).
There is both indirect and direct evidence for an important role of cerebellar NE in delay
eyeblink conditioning. The previously discussed work by Gould (1998) demonstrated that
systemic propranolol given daily prior to delay eyeblink conditioning sessions slowed the
rate of acquisition and increased the number of days required to reach a learning criterion in
rabbits. In rats, effects of systemic propranolol were more severe, with subjects performing
no better than unpaired controls after six days of conditioning under higher propranolol
doses similar to those producing effects in the Gould and current rabbit study (Cartford et
al., 2002). Intra-brain injections of propranolol in rats targeting cerebellar lobule HVI and
the IP (Cartford et al., 2004) or cerebellar cortex (Paredes et al., 2009) have also led to
impaired acquisition. In vivo microdialysis in rats has demonstrated that cerebellar NE
increases during delay eyeblink conditioning, peaking early in training, with no increases
observed in subjects given unpaired CS/US presentations (Paredes et al., 2009). In addition,
functional β-adrenergic receptors have been documented within the rat DCN, and βadrenergic agonists have been shown to modulate inhibition of DCN cell firing (Gould et al.,
1997). Whether cerebellar NE may modulate extinction, however, is less clear. Depletion of
NE via locus coeruleus lesions in rabbits trained with delay eyeblink conditioning followed
by unpaired extinction showed extinction impairments that correlated with depletion of NE
in the hippocampus and frontal cortex but not in the cerebellum (McCormick and
Thompson, 1982). Future studies examining direct manipulations of amygdala and/or
cerebellar NE with intra-brain infusions of propranolol, for example, would help further our
understanding of the neural mechanisms behind the behavioral effects of systemic
propranolol in our model.

Author Manuscript
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As dysregulation of NE signaling has been proposed to underlie PTSD symptomology
(Hendrickson and Raskind, 2016; Southwick et al., 1999; Strawn and Geracioti, 2008), the
use of propranolol as a treatment to block fear memory reconsolidation or enhance
extinction has been investigated in both the clinical population as well as in healthy humans.
With PTSD patients, results have been mixed with some studies showing promise of
persistent improvement in symptoms or lessened physiological responding to trauma recall
when propranolol is used in combination with reactivation of the trauma memory (Brunet et
al., 2008; Brunet et al., 2011; Brunet et al., 2014), but results are not consistently replicable
(Wood et al., 2015). In addition, meta-analysis of studies examining effects of propranolol
given shortly after trauma when arousal levels are high, a situation similar to immediate
extinction in animals, showed that propranolol did not reduce PTSD incidence (Argolo et al.,
2015). Extensive experiments conducted by Kindt and colleagues on healthy humans using
fear conditioning protocols have also shown inconsistent effects of propranolol when given
prior to reactivation of fear memory, with some demonstrating fear attenuation in later
retention tests (Kindt et al., 2009) that can be dissociated from an intact declarative memory
for the CS-US association (Soeter and Kindt, 2010), but also null results during replications
(Bos et al., 2014; Schroyens et al., 2017). In a human fear conditioning study where
propranolol was given prior to extinction (repeated CS presentations), propranolol did not
affect the physiological fear response but did impair cognitive extinction memory.
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Replication challenges and complications from conscious versus unconscious fear memories
in human studies further highlight the need to also examine animal models for further
clarification on how and why propranolol may benefit the clinical population.
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Overall, findings from our study suggest that propranolol may provide the most therapeutic
benefit in situations where arousal level is elevated, such as at the beginning of treatment or
when the cognitive behavioral therapy itself evokes a higher arousal level. One such
treatment is the use of virtual reality therapy (VRT) where subjects are immersed in multisensory virtual environments representative of the trauma experience. VRT has shown great
promise to be an effective PTSD treatment, particularly in military combat PTSD (MaplesKeller et al., 2017; Rizzo et al., 2011). We are unaware of any clinical or healthy human
studies combining propranolol with VRT, so it would be interesting to see if propranolol
may be uniquely suited to enhance efficacy of this type of therapy. The lack of long-term
beneficial effects of propranolol, however, suggests that propranolol may have the most
impact early in therapy. For example, if propranolol facilitates extinction during the first
cognitive behavioral therapy session, patients may be less inclined to drop-out if they feel
like therapy is working early on, especially if a more intense/distressing treatment like VRT
is used. Importantly, propranolol also has the potential to address more than one PTSD
symptom, such as conditioned fear to trauma-associated cues as well as hyperarousal.
Because traditional exposure therapies tend to focus solely on extinguishing fear to cues
associated with trauma, we had previously examined whether extinction treatment involving
CS-alone presentations had any effect on CRM (Schreurs et al., 2000). This earlier work and
a later extinction study that also examined context extinction and continued CS-US pairings
with a weak US (Burhans et al., 2015), demonstrated that only treatments that incorporated
US-alone presentations had any significant impact on CRM. In summary, these findings
suggested that traditional exposure therapy may not adequately address hyperarousal
symptoms. Adding presentations of unsignaled, innately stressful (but mild) stimuli such as
skin stimulation may help alleviate hypervigilance symptoms, which would be easy to
incorporate into the immersive, multisensory environment of VRT therapy.

Author Manuscript

Highlighting the translatability of our CRM model from rabbits to humans, there is a
growing body of literature utilizing the eyeblink conditioning paradigm to study patients
with PTSD (Ayers et al., 2003; Burriss et al., 2007; Handy et al., 2018). Newer reports using
eyeblink conditioning with a partial reinforcement schedule (CS- or US-alone trials
interspersed with paired CS-US trials) have demonstrated that individuals with PTSD or
personality traits that increase vulnerability to anxiety-disorders like PTSD have enhanced
acquisition of delay eyeblink conditioning (Allen et al., 2018; Allen et al., 2016) and can
also show resistance to extinction (Allen et al., 2014; Handy et al., 2018). Interestingly,
Wistar-Kyoto mice, used to model anxiety-vulnerability, also show enhanced delay eyeblink
conditioning (Ricart et al., 2011). By analyzing large pools of rabbit data collected with our
CRM model, we have previously sought to determine whether factors, such as conditioning
rates or levels, can predict individual susceptibility or resilience to CRM (Smith-Bell et al.,
2012; Smith-Bell and Schreurs, 2017). We have found that subjects that went on to develop
strong CRM took fewer trials to reach a learning criterion (Smith-Bell and Schreurs, 2017)
and also that CR amplitude and area was positively correlated with the size of CRM (SmithBell et al., 2012). Interestingly, larger amplitude CRs have also been reported in veterans
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with PTSD in addition to increased amplitude URs during trace eyeblink conditioning
(Burriss et al., 2007), suggesting that CRM-like changes in PTSD patients may be detectable
as well. Also of note, US-alone pre-exposure in anxiety- prone individuals disrupts enhanced
conditioning (Allen and Miller, 2016), suggesting that our model, which includes US-alone
presentations during Pretest prior to conditioning, may preclude us from detecting a stronger
relationship between conditioning levels and CRM susceptibility. In addition, our rabbits are
conditioned daily for a total of six sessions yielding high, sustained performance levels prior
to CRM assessment, unlike human studies that typically only use a single session. To further
bridge the gap to the clinical data, we might consider future studies using a more
challenging partial reinforcement schedule, which may improve the ability of our model to
detect and predict a PTSD-like phenotype and enhance sensitivity to drug effects. Likewise,
clinical studies may benefit from looking for CRM-like changes in the UR, as it may be
another defining feature of PTSD patients or anxiety-prone individuals. Overall, these
findings from both animals and humans support the utility of eyeblink conditioning as a tool
to identify a PTSD phenotype, predict susceptibility, and test behavioral and
pharmacological treatments that can be easily translated from the bench to bedside and vice
versa.

8. Conclusions

Author Manuscript

In conclusion, findings presented here further validate our CRM eyeblink conditioning
model of PTSD by showing that extinction of trauma-associated cues and conditioned
hyperarousal are both sensitive to noradrenergic manipulation, dysfunction of which is
strongly implicated in PTSD. Our results suggest that propranolol may provide the most
benefit early during extinction therapy when arousal levels are high, which may offer
incentive to patients to continue with treatment, thereby improving patient outcomes. The
rabbit CRM model of PTSD and complimentary, ongoing work using the eyeblink paradigm
to examine PTSD and anxiety-vulnerability in humans demonstrate the important utility of
eyeblink conditioning to further our understanding of the neurobiological mechanisms of
PTSD and the neuropharmacology of treatments.
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Highlights
•

Propranolol facilitates within-session extinction of conditioned eyeblink
responses

•

Propranolol enhances extinction of conditioned hyperarousal short-term

•

Propranolol provides the most benefit early in extinction when arousal level
high

•

Propranolol may improve compliance rather than long-term treatment
outcomes
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The mean percentage (± SEM) of conditioned responses (% CRs) to the tone conditioned
stimulus (CS) during six daily sessions of delay conditioning, six daily sessions of unpaired
extinction with weak shock combined with saline or propranolol injection, and a CR
retention test consisting of CS-alone presentations (CS Test). The boxed inset panel shows
the mean percentage (± SEM) of unconditioned responses (% URs) to the 0.3 mA shock
presented during extinction. Prior to the unpaired extinction sessions, rabbits received saline
(open circle) or 3 mg/kg (light grey triangle), 6 mg/kg (dark grey diamond), or 12 mg/kg
propranolol (black square).
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The mean percentage (± SEM) of conditioned responses (% CRs) to the tone conditioned
stimulus (CS) during six daily sessions of unpaired extinction with weak shock combined
with saline or propranolol injection, averaged in 10 trial blocks of CS presentations for each
session. Prior to the unpaired extinction sessions, rabbits received saline (open circle) or 3
mg/kg (light grey triangle), 6 mg/kg (dark grey diamond), or 12 mg/kg propranolol (black
square).
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Figure 3.

Topographies for the averaged unconditioned response to the periorbital shock
unconditioned stimulus (US) during the first 20 trials of the US pretest (Pretest, black dotted
line), the posttest following delay conditioning (Post1, red line), and the posttest following
extinction combined with saline or propranolol injection (Post2, blue line). Topographies are
shown at the five unconditioned stimulus intensities (2.0, 1.0, 0.5, 0.3, 0.1 mA) presented
during US testing, collapsed across duration.
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Figure 4.

The mean percentage (± SEM) of conditioned responses (% CRs) to the tone conditioned
stimulus (CS) during six daily sessions of delay conditioning, one session of unpaired
extinction with weak shock following saline (open circle) or 12 mg/kg propranolol injection
(black square), and a CR retention test consisting of CS-alone presentations eight days later
(CS Test). CRs during extinction and the CS Test session are shown averaged across the
entire session and in 10 trial blocks of CS presentations. The boxed inset panel shows the
mean percentage (± SEM) of unconditioned responses (% URs) to the 0.3 mA shock
presented during extinction, averaged across the entire session.
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Figure 5.

Topographies for the averaged unconditioned response to the periorbital shock
unconditioned stimulus (US) during the first 20 trials of the US pretest (Pretest, black dotted
line), the posttest following delay conditioning (Post1, red line), the posttest following a
single extinction session combined with saline or 12 mg/kg propranolol injection (Post2,
blue line), and a third posttest one week later (Post3, green). Topographies are shown at the
five unconditioned stimulus intensities (2.0, 1.0, 0.5, 0.3, 0.1 mA) presented during US
testing, collapsed across duration.
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Figure 6.

Mean (± SEM) magnitude of the unconditioned response (UR) amplitude (left column) and
area (left middle column), onset latency (right middle column), and peak latency (right
column) to the intermediate unconditioned stimulus intensities (1.0, 0.5, 0.3 mA) for the first
20 trials of each of four US tests, collapsed across duration. Pretest (striped bar) and Post1
(black bar) took place prior to and following delay conditioning, respectively, whereas Post2
(white bar) and Post3 (gray bar) occurred one day and one week following a single session
of unpaired extinction with weak shock combined with saline (top row) or 12 mg/kg
propranolol (bottom row) injection.
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Figure 7.
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Unconditioned response (UR) topographies for four individual propranolol subjects, two
exhibiting strong CRM (top row, strong CRM responses indicated by asterisks) and two
exhibiting more moderate CRM (bottom row). Data shown are the UR to the periorbital
shock unconditioned stimulus (US) during the first 20 trials of the US pretest (Pretest, black
dotted line), the posttest following delay conditioning (Post1, red line), the posttest
following a single session of unpaired extinction combined with a 12 mg/kg propranolol
injection (Post2, blue line), and a third posttest one week later (Post3, green). Topographies
are shown at three intermediate US intensities (1.0, 0.5, 0.3 mA) presented during US
testing, collapsed across duration.
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